110
Participants
Start Date
March 20, 2015
Primary Completion Date
April 20, 2021
Study Completion Date
April 20, 2021
alglucosidase alfa
Alglucosidase alfa IV infusion of 20 mg/kg; qow
Investigational Site Number 056002, Leuven
Investigational Site Number 056003, Leuven
Investigational Site Number 056001, Ghent
Investigational Site Number 158001, Taipei
Investigational Site Number 203001, Prague
Investigational Site Number 840014, Pittsburgh
Investigational Site Number 840004, Hershey
Investigational Site Number 380005, Milan
Investigational Site Number 840001, Fairfax
Investigational Site Number 380001, Brescia
Investigational Site Number 840002, Durham
Investigational Site Number 380004, Padua
Investigational Site Number 840008, Salt Lake City
Investigational Site Number 840016, Phoenix
Investigational Site Number 380006, Messina
Investigational Site Number 276002, Halle
Investigational Site Number 380002, Cagliari
Investigational Site Number 380003, Roma
Genzyme, a Sanofi Company
INDUSTRY